|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Origination of loans for sale | |||||
| Sale of loans originated for sale | |||||
| Depreciation and amortization, net of accretion | |||||
| Deferred tax expense (benefit) | |||||
| Stock based compensation expense | |||||
| Cash payments for lease liabilities | |||||
| (Gain) loss on sale of securities, net | |||||
| (Gain) loss on tax credit investment | |||||
| (Gain) loss on sale of loans held-for-sale, net | |||||
| Net (gain) recognized on sale of premises and equipment | |||||
| Impairment charge on assets held for sale | |||||
| Gain on sale of real estate | |||||
| Increase of cash value of bank owned life insurance | |||||
| (Gain) loss on sale of property and equipment | |||||
| (Gain) loss on sale of foreclosed real estate | |||||
| (Increase) decrease of cash value of bank owned life insurance | |||||
| (Gain) loss on death benefits of bank-owned life insurance | |||||
| (Gain) loss on derivatives | |||||
| Provision for loan losses | |||||
| Provision for credit losses | |||||
| Provision for (benefit from) credit losses | |||||
| Interest receivable | |||||
| Interest payable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Total adjustments | |||||
| Net cash provided by (used in) operating activities | |||||
| Proceeds from maturities of certificates of deposit in other financial institutions | |||||
| Purchase of certificates of deposit in other financial institutions | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Proceeds from maturities and pay downs of securities available-for-sale | |||||
| Proceeds from sales of securities available-for-sale | |||||
| Purchase of securities available-for-sale | |||||
| Net change in loans receivable | |||||
| Proceeds from loans held for sale previously classified as loans receivable | |||||
| Purchase of Federal Home Loan Bank Stock | |||||
| Purchase of loans receivable | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sale of foreclosed real estate | |||||
| Cash and cash equivalents from acquisition activity, net | |||||
| Proceeds from death benefits of bank owned life insurance | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Change in deposits | |||||
| Proceeds from borrowed funds | |||||
| Repayment of borrowed funds | |||||
| Net surrender value of restricted stock awards | |||||
| Change in repurchase agreements | |||||
| Change in federal funds purchased and repurchase agreements | |||||
| Dividends paid | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||
| Interest | |||||
| Income taxes | |||||
| Fair value of assets acquired, including cash and cash equivalents | |||||
| Value of goodwill and other intangible assets | |||||
| Fair value of liabilities assumed | |||||
| Cash paid for acquisition | |||||
| Issuance of common stock for acquisition | |||||
| Noncash activities: | |||||
| Transfer of loans receivable to loans held for sale | |||||
| Dividends declared not paid | |||||
| Transfer of premises and equipment to other real estate | |||||
| Initial recoginition of ASU 2016-13 | |||||
| Accounting Standards Update 2016-13 | |||||
| Total initial recoginition of ASU 2016-13 | |||||
| Right-of-use asset obtained in exchange for lease liability | |||||
| Loans transferred to other real estate owned | |||||
Loading...
